COIL — Coiled Therapeutics Share News
0.000.00%
Last trade - 00:00Coiled Therapeutics - Clinical Trial Update
RCS - Roquefort Theraptcs. - Investor Presentation
Roquefort Theraptcs. - Proposed Acquisition and Fundraise of £8.5 million
Press Digest: British Business - March 2
RCS - Roquefort Theraptcs. - Research Note Published
Brief: Roquefort Therapeutics Extends AO-252 License Agreement To 16 March 2026
Roquefort Theraptcs. - Clinical Trial & License Agreement Update
Roquefort Theraptcs. - Conversion of CLNs
Roquefort Theraptcs. - Holding(s) in Company
Roquefort Theraptcs. - Director/PDMR Shareholding
Roquefort Theraptcs. - Executed License Agreement & Transaction Update
Brief: Roquefort Therapeutics Out-Licenses MK Cell Patents For Up To $25 Mln
Roquefort Theraptcs. - Fundraise & Transaction Update
Roquefort Theraptcs. - Interim Results to 30 June 2025
RCS - Roquefort Theraptcs. - Investor Presentation via Engage Investor
Brief: Roquefort Therapeutics Announces Acquisition Of Coiled USA
Roquefort Theraptcs. - Proposed Acquisition of Clinical Stage Company
Brief: Roquefort Therapeutics Extends Lyramid Sale Deadline To 31 October
Roquefort Theraptcs. - Director/PDMR Shareholding